The authors declare no conflict of interest.
MLL2 mosaic mutations and intragenic deletion–duplications in patients with Kabuki syndrome
Article first published online: 18 SEP 2012
© 2012 John Wiley & Sons A/S
Volume 83, Issue 5, pages 467–471, May 2013
How to Cite
MLL2 mosaic mutations and intragenic deletion–duplications in patients with Kabuki syndrome., , , , , , , , , , .
- Issue published online: 5 APR 2013
- Article first published online: 18 SEP 2012
- Accepted manuscript online: 17 AUG 2012 10:58AM EST
- Manuscript Revised: 13 AUG 2012
- Manuscript Accepted: 13 AUG 2012
- Manuscript Received: 28 JUN 2012
|cge1955-sup-0001-figureS1.doc||Word document||41K||Fig S1. Pyrosequencing results: pyrogram showing a quantitative peak profile of patient 1 compared to a control sample.|
|cge1955-sup-0002-figureS2.doc||Word document||429K||Fig S2. Chromatograph from bi-directional Sanger sequencing of exon 34 of MLL2 of patient 2, using two additional primer sets.|
|cge1955-sup-0003-tableS1.doc||Word document||33K||Table S1. Sequences of the primer used for pyrrosequncing and sequencing.|
|cge1955-sup-0004-AppendixS1.doc||Word document||32K||Appendix S1. Pyrrosequencing.|
|cge1955-sup-0005-AppendixS2.doc||Word document||30K||Appendix S2. Sequencing.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.